发明名称 |
USE OF CLADRIBINE FOR TREATING NEUROMYELITIS OPTICA |
摘要 |
2-Chloro-2'-deoxyadenosine, hereinafter referred to as cladribine, or a pharmaceutically acceptable salt thereof may be used in the treatment or amelioration of neuromyelitis optica, hereinafter referred to as NMO e.g. in patients known to have NMO - IgG seropositivity or in patients optic neuritis, myelitis and at least two of MRI evidence of contiguous spinal cord lesion 3 or more segments in length, onset brain MRI nondiagnostic for multiple sclerosis or NMO - IgG seropositivity. |
申请公布号 |
WO2015114315(A1) |
申请公布日期 |
2015.08.06 |
申请号 |
WO2015GB50177 |
申请日期 |
2015.01.27 |
申请人 |
CHORD THERAPEUTICS S.A.R.L.;LUCAS, BRIAN RONALD |
发明人 |
ROACH, ARTHUR HENRY;REJDAK, KONRAD |
分类号 |
A61K31/7076;A61K38/21;A61P25/00 |
主分类号 |
A61K31/7076 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|